申请人:Kobayashi Motomasa
公开号:US20130065937A1
公开(公告)日:2013-03-14
A compound represented by the general formula (C):
(wherein R
101
represents a substituted or unsubstituted aromatic heterocyclic group,
R
102
, R
103
, R
104
and R
105
may be the same or different, and each represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 3 carbon atoms, or a haloalkyl group having 1 to 3 carbon atoms, and
R
106
represents a hydrogen atom, or a saturated or unsaturated hydrocarbon group which is a straight or branched chain having 1 to 12 carbon atoms, but
excluded is the case where R
101
is a 3-furyl group, R
102
, R
103
, R
104
and R
105
are all methyl groups, and R
106
is a methyl group, a 4-methyl-3-pentenyl group or a 4,8-dimethyl-3,7-nonadienyl group); or
a pharmaceutically acceptable salt thereof has selective inhibitory activity on hypoxic cell growth in a broad range of the concentration and therefore is useful as an active ingredient of a medicament for cancer prevention or treatment.